how does semaglutide increase metabolism targets MASH molecular pathways beyond weight loss Semaglutide as a GLP-1 Agonist:

Robert, L., VanEtten, R

According to the National Institutes of Health (NIH- department of the HHS), there is concern for acute pancreatitis and long-term consequences on the thyroid gland with usage of the GLP-1 RA medication

Some patients may experience unexplained weight loss

(2021), most patients see measurable improvements within 36 months of consistent use, with continued improvement up to 12 months

19 : 65 - 76 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T

3 cohorts, 248 participants) The critical mechanistic link: selenium exerts its thyroid-protective effects primarily through glutathione peroxidase - the selenoprotein enzyme that uses glutathione as its substrate